Hani Mawardi

Prof. Hani Mawardi

King Abdulaziz University, Jeddah, Makkah al Mukarramah, Saudi Arabia
orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 April 2011 in Bone Marrow Transplantation
Verified
Journal Article
Open access
PDF file
HMHani Mawardi
Hani Mawardi
SES Elad
S Elad
MCM E Correa
M E Correa
KSK Stevenson
K Stevenson
SWS-B Woo
S-B Woo
NTN Treister
N Treister
Late complications of allogeneic hematopoietic stem cell transplantation (HSCT) include a risk of secondary malignancies. Optimization for early diagnosis and treatment of oral premalignant or malignant lesions requires an assessment of potential predisposing risk factors. The medical records of patients who developed oral epithelial dysplasia (OED) and oral squamous cell carcinoma (OSCC) following allogeneic-HSCT were reviewed. Data on HSCT course, chronic graft-versus-host disease (cGVHD), and clinical outcome were recorded; landmark survival was calculated. Twenty-six patients with OED (n=8) and OSCC (n=18) were identified with a median follow-up of 26.5 and 21.5 months, respectively. Premalignant and malignant oral lesions were diagnosed at a median time of 2.5 and 8 years after HSCT, respectively. Chronic GVHD was present in 96% of patients and of these, 96% had oral involvement. Multifocal oral cancer was found in 28% of cases, and localized recurrence was observed in 44% of cases. These results suggest that oral cGVHD may be considered a potential risk factor for the development of OSCC following allogeneic-HSCT. The observation that oral cancers were frequently multifocal and recurred locally suggests that these cancers may be more aggressive. Vigilant follow-up and coordination of care are critical.

1 March 2009 in Journal of Oral and Maxillofacial Surgery
Verified
Journal Article
Closed access
HMHani Mawardi
Hani Mawardi
NTNathaniel Treister
Nathaniel Treister
PRPaul Richardson
Paul Richardson
KAKenneth Anderson
Kenneth Anderson
NMNikhil Munshi
Nikhil Munshi
SWSook-Bin Woo
Sook-Bin Woo

15 September 2011 in Journal of Dental Research
Verified
Journal Article
Closed access
PDF file
HMHani Mawardi
Hani Mawardi
GGGabriela Giro
Gabriela Giro
Mikihito KajiyaMikihito Kajiya
Mikihito Kajiya
KOK. Ohta
K. Ohta
SAS. Almazrooa
S. Almazrooa
TKT. Kawai
T. Kawai
No consensus has yet been reached to associate oral bacteria conclusively with the etio-pathogenesis of bisphosphonate-induced osteonecrosis of the jaw (BONJ). Therefore, the present study examined the effects of oral bacteria on the development of BONJ-like lesions in a mouse model. In the pamidronate (Pam)-treated mice, but not control non-drug-treated mice, tooth extraction followed by oral infection with Fusobacterium nucleatum caused BONJ-like lesions and delayed epithelial healing, both of which were completely suppressed by a broad-spectrum antibiotic cocktail. Furthermore, in both in vitro and in vivo experiments, the combination of Pam and Fusobacterium nucleatum caused the death of gingival fibroblasts (GFs) and down-regulated their production of keratinocyte growth factor (KGF), which induces epithelial cell growth and migration. Therefore, in periodontal tissues pre-exposed to bisphosphonate, bacterial infection at tooth extraction sites caused diminished KGF expression in GFs, leading to a delay in the epithelial wound-healing process that was mitigated by antibiotics.

16 February 2017 in The Oncologist
Verified
Journal Article
Closed access
PDF file
ASAhmed S. Sultan
Ahmed S. Sultan
GHGlenn J. Hanna
Glenn J. Hanna
DMDanielle N. Margalit
Danielle N. Margalit
NCNicole Chau
Nicole Chau
LGLaura A. Goguen
Laura A. Goguen
HMHani Mawardi
Hani Mawardi
Background: Osteoradionecrosis of the jaw (ORN) is an infrequent yet potentially devastating complication of radiation therapy to the head and neck region. Treatment options include antimicrobial therapy, local sequestrectomy, resection, and the use of hyperbaric oxygen (HBO). Published data on ORN are difficult to compare because of the lack of a universally accepted classification and staging system, and the literature on the use of HBO to either prevent or successfully manage ORN is controversial and inconclusive. Therefore, we aimed to establish a standard approach for using HBO at our institution. Materials and Methods: A literature search was conducted of articles published in the English language between January 1980 and January 2016. Retrieved articles were evaluated by two independent reviewers. Isolated case reports, abstracts, case series, review articles, and cohort studies without a control group were excluded; summary data were extracted from the remaining studies. A panel of experts from Head and Neck Oncology and Oral Medicine from the Dana-Farber Cancer Institute and Brigham and Women’s Hospital reviewed the summary data and established multidisciplinary guidelines on the use of HBO for the prevention and management of ORN. Results: Seven studies were evaluated and reviewed by the multidisciplinary panel. There was no consistent evidence in support of HBO for either the prevention or management of ORN. Conclusion: Based on the available evidence and expert opinion, routine use of HBO for the prevention or management of ORN is not recommended and is rarely used at our institution.

15 November 2016 in The Journal of Immunology
Verified
Journal Article
Open access
PDF file
HKHiroyuki Kanzaki
Hiroyuki Kanzaki
SMSeicho Makihira
Seicho Makihira
M2Maiko 296437751
Maiko 296437751
TITakenobu Ishii
Takenobu Ishii
AMAlexandru Movila
Alexandru Movila
TKToshihisa Kawai
Toshihisa Kawai
Host immune responses play a key role in promoting bone resorption in periodontitis via receptor activator of NF-κB ligand (RANKL)–dependent osteoclastogenesis. Both membrane-bound RANKL (mRANKL) expressed on lymphocytes and soluble RANKL (sRANKL) are found in periodontal lesions. However, the underlying mechanism and cellular source of sRANKL release and its biological role in periodontitis are unclear. TNF-α–converting enzyme (TACE) is reported to cleave the following: 1) precursor TNF-α with release of mature, soluble TNF-α and 2) mRANKL with release of sRANKL. Both soluble TNF-α and sRANKL are found in the periodontitis lesion, leading to the hypothesis that TACE expressed on lymphocytes is engaged in RANKL shedding and that the resulting sRANKL induces osteoclastogenesis. In the current study, upon stimulating PBLs with mitogens in vitro, RANKL expression, sRANKL secretion, and TACE expression were all upregulated. Among the four putative mRANKL sheddases examined in neutralization assays, TACE was the only functional sheddase able to cleave mRANKL expressed on PBL. Moreover, PBL culture supernatant stimulated with mitogens in the presence of anti-TACE Ab or anti-RANKL Ab showed a marked reduction of osteoclastogenesis from osteoclast precursors, indicating that TACE-mediated sRANKL may possess sufficient osteoclastogenic activity. According to double-color confocal microscopy, B cells expressed a more pronounced level of RANKL and TACE expression than T cells or monocytes in periodontally diseased gingiva. Conditioned medium of patients’ gingival lymphocyte culture increased in vitro osteoclastogenic activity, which was suppressed by the addition of anti-TACE Ab and anti-RANKL Ab. Therefore, TACE-mediated cleavage of sRANKL from activated lymphocytes, especially B cells, can promote osteoclastogenesis in periodontitis.

13 March 2018 in The FASEB Journal
Verified
Journal Article
Open access
PDF file
TITakenobu Ishii
Takenobu Ishii
MRMontserrat Ruiz‐Torruella
Montserrat Ruiz‐Torruella
AIAtsushi Ikeda
Atsushi Ikeda
SSSatoru Shindo
Satoru Shindo
AMAlexandru Movila
Alexandru Movila
Satoru ShindoSatoru Shindo
Satoru Shindo
Cell fusion‐mediated formation of multinuclear osteoclasts (OCs) plays a key role in bone resorption. It is reported that 2 unique OC‐specific fusogens [ i.e. , OC‐stimulatory transmembrane protein (OC‐STAMP) and dendritic cell–specific transmembrane protein (DC‐STAMP)], and permissive fusogen CD9, are involved in OC fusion. In contrast to DC‐STAMP‐knockout (KO) mice, which show the osteopetrotic phenotype, OC‐STAMP‐KO mice show no difference in systemic bone mineral density. Nonetheless, according to the ligature‐induced periodontitis model, significantly lower level of bone resorption was found in OC‐STAMP‐KO mice compared to WT mice. Anti‐OC‐STAMP‐neutralizing mAb down‐modulated in vitro: 1 ) the emergence of large multinuclear tartrate‐ resistant acid phosphatase‐positive cells, 2) pit formation, and 3) mRNA and protein expression of CD9, but not DC‐STAMP, in receptor activator of NF‐κB ligand (RANKL)‐stimulated OC precursor cells (OCps). While anti–DC‐STAMP‐mAb also down‐regulated RANKL‐induced osteoclastogenesis in vitro , it had no effect on CD9 expression. In our mouse model, systemic administration of anti–OC‐STAMP‐mAb suppressed the expression of CD9 mRNA, but not DC‐STAMP mRNA, in periodontal tissue, along with diminished alveolar bone loss and reduced emergence of CD9 + OCps and tartrate‐resistant acid phosphatase‐positive multinuclear OCs. The present study demonstrated that OC‐STAMP partners CD9 to promote periodontal bone destruction by up‐regulation of fusion during osteoclastogenesis, suggesting that anti–OC‐STAMP‐mAb may lead to the development of a novel therapeutic regimen for periodontitis.—Ishii, T., Ruiz‐Torruella, M., Ikeda, A., Shindo, S., Movila, A., Mawardi, H., Albassam, A., Kayal, R. A., Al‐Dharrab, A. A., Egashira, K., Wisitrasameewong, W., Yamamoto, K., Mira, A. I., Sueishi, K., Han, X., Taubman, M. A., Miyamoto, T., Kawai, T. OC‐STAMP promotes osteoclast fusion for pathogenic bone resorption in periodontitis via up‐regulation of permissive fusogen CD9. FASEB J. 32, 4016–4030 (2018). www.fasebj.org